Table 2.

Baseline characteristics of patients who underwent allo-HSCT

	DLBCL, n = 1220	FL, n = 896	HL, n = 342	MCL, n = 154	BL, n = 124	PTCL-NOS, n = 457	AITL, n = 209	ALCL, n = 176	MF/SS, n = 100	ENKTL, n = 335
Median age (range), y	52 (2-73)	53 (2-76)	30.5 (1-68)	57.5 (23-73)	30 (3-68)	49 (3-73)	55 (17-72)	35 (3-73)	44 (23-68)	45 (1-70)
>60 y, n	230	142	8	52	4	85	48	15	12	27
Sex, male, n	703	470	220	121	93	303	134	129	57	216
Stage, III or IV, n	954	793	218	141	105	390	198	139	76	186
Extranodal sites, >1, n	421	208	NA	54	57	168	64	63	36	137
IPI, high-int or high, n	483	174	NA	48	74	189	95	54	27	117
Stage at HSCT, CR or Cru, n	319	217	73	50	42	108	51	52	11	148
ECOG-PS at HSCT, 0-1, n	912	776	283	131	71	365	159	121	82	279